ESC 2021: EMPEROR-Preserved Strongly Supports Use of Empagliflozin for Heart Failure With Preserved Ejection Fraction
Clinicians need not wait for updated guidelines to start using the drug in appropriate heart failure patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.